Prudential Earnings Calls
| Release date | Mar 18, 2026 |
| EPS estimate | $0.710 |
| EPS actual | $1.04 |
| EPS Surprise | 46.48% |
| Revenue estimate | 15.417B |
| Revenue actual | 15.417B |
| Release date | Mar 17, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Aug 26, 2025 |
| EPS estimate | $0.460 |
| EPS actual | $0.519 |
| EPS Surprise | 12.83% |
| Revenue estimate | - |
| Revenue actual | 18.256B |
| Release date | May 23, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Prudential
Below you can see how PUKPF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | May 23, 2025 |
| Price on release | $11.35 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| May 19, 2025 | $9.45 |
| May 20, 2025 | $11.35 |
| May 21, 2025 | $11.35 |
| May 22, 2025 | $11.35 |
| May 23, 2025 | $11.35 |
| May 27, 2025 | $7.46 |
| May 28, 2025 | $11.35 |
| May 29, 2025 | $11.35 |
| May 30, 2025 | $11.35 |
| 4 days before | 20.11% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 20.11% |
| Release date | Aug 26, 2025 |
| Price on release | $12.78 |
| EPS estimate | $0.460 |
| EPS actual | $0.519 |
| EPS surprise | 12.83% |
| Date | Price |
|---|---|
| Aug 20, 2025 | $12.35 |
| Aug 21, 2025 | $12.78 |
| Aug 22, 2025 | $12.78 |
| Aug 25, 2025 | $12.78 |
| Aug 26, 2025 | $12.78 |
| Aug 27, 2025 | $12.78 |
| Aug 28, 2025 | $12.78 |
| Aug 29, 2025 | $7.46 |
| Sep 02, 2025 | $12.78 |
| 4 days before | 3.48% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 3.48% |
| Release date | Mar 17, 2026 |
| Price on release | $16.10 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Mar 11, 2026 | $16.10 |
| Mar 12, 2026 | $16.10 |
| Mar 13, 2026 | $16.10 |
| Mar 16, 2026 | $16.10 |
| Mar 17, 2026 | $16.10 |
| Mar 18, 2026 | $16.10 |
| Mar 19, 2026 | $16.10 |
| Mar 20, 2026 | $16.10 |
| Mar 23, 2026 | $16.10 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Mar 18, 2026 |
| Price on release | $16.10 |
| EPS estimate | $0.710 |
| EPS actual | $1.04 |
| EPS surprise | 46.48% |
| Date | Price |
|---|---|
| Mar 12, 2026 | $16.10 |
| Mar 13, 2026 | $16.10 |
| Mar 16, 2026 | $16.10 |
| Mar 17, 2026 | $16.10 |
| Mar 18, 2026 | $16.10 |
| Mar 19, 2026 | $16.10 |
| Mar 20, 2026 | $16.10 |
| Mar 23, 2026 | $16.10 |
| Mar 24, 2026 | $16.10 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Prudential Earnings Call Transcript Summary of Q4 2025
Prudential plc reported strong 2025 results with double-digit, high-quality growth across key metrics and progress on its five-year transformation. New business profit (NBP) and adjusted operating profit after tax per share both grew 12%; gross OFSG and dividend per share rose 15%. Management highlighted consistent quarterly NBP growth in 2025, an 18% CAGR in NBP from 2022–2025, and improved capital generation with gross OFSG up 15% and net OFSG up 22%. Strategic moves included the Indian asset management IPO (proceeds to be returned to shareholders), increasing holding in Malaysian conventional business to 70%, and continued investment in agency transformation (productivity up, recruitment initiatives like PRUVentures) and technology (PruForce, AI-enabled PruAction). The group’s free surplus ratio remained strong (221% or 204% excluding IPO proceeds) and S&P upgraded the financial strength rating to AA. Capital policy: management expects to return over $7bn of capital to shareholders between 2024–2027, including a $1.2bn buyback launched in January (to complete by end-2026), $500m additional return in 2025 and $600m expected in 2027, and guidance for >10% DPS growth per year 2025–2027. 2026 guidance is for continued double-digit growth; management remains confident in achieving 2027 objectives (including improved variances returning to positive by 2027). Key regional notes: very strong China performance (27% NBP growth), bancassurance performing exceptionally well (NBP > $1bn; ~95% of lower end of 2027 bancassurance objective), mixed agency results (productivity up but active agents down in some ASEAN markets), and targeted expansion of PRUVentures and tech-enabled agent tools across markets. Financial outlook: continued capability investment ($300–$350m in 2026 expected to largely complete the program), focus on cost containment and operating leverage, and expectation of further margin and cash profile improvement via mix (health/protection) and agency improvements.
Sign In
Buy PUKPF